Compass Diversified: Aligning Manager Fees, Deleveraging, and a Turnaround at Altor

Driving the Core While Stumbling at Altor

Compass Diversified's second-quarter results tell a tale of two portfolios. On a comparable basis (excluding Lugano and the divested Sterno foodservice business), subsidiary adjusted EBITDA rose 12.6% year-over-year, with Branded Consumer up 24.2% — led by BOA (+27%) and Honey Pot (+32%) — while Industrial declined 12.8%. The pain is concentrated in Altor, where adjusted EBITDA fell roughly 50% due to tariff-disrupted white-goods demand, softer vaccine logistics, and higher input costs. Management is blunt:

Q2 was a very challenging quarter, some external factors, some internal factors... the recovery to stretch modestly over a handful of future quarters.

A Governance Reset

The most consequential news this quarter was the amendment to the management services agreement (MSA). After a Board-led review, CODI cut the base management fee from 2% to 1.25% of average adjusted net assets on the first $3B, capped the 2027 fee at $30M, and added two 12.5bp awards tied to share ownership and shareholder returns. CEO Elias Sabo noted: “The amendment followed a Board-led review that considers investor perspectives and market practices. It lowers fees and ties more of the manager's compensation to shareholder returns and operating performance.” — Elias Sabo, Chief Executive Officer · 2026-08-10 This is a meaningful shift in the fee structure, effectively lowering expected 2027 fees by ~$20M. It also follows the leadership transition: Sabo will retire at year-end, with COO Zach Sawtelle promoted to CEO. On the prior call, when asked about MSA changes, Sabo said “We are not in a position yet to start to discuss that.” — Elias Sabo, Chief Executive Officer · 2026-05-06 Now the details are out, confirming a clear move to align manager incentives with public shareholders.

Deleveraging and Cash Flow

The balance sheet is improving faster than expected. The sale of Sterno's foodservice business generated ~$280M of debt reduction, bringing total debt to ~$1.6B. Covenant leverage dropped from 5.3x to 4.8x sequentially, with senior secured net leverage at 0.66x. CFO Stephen Keller reiterated the long-term target: “Long term, we've always said we'd like to be around 3x to 3.5x levered.” — Stephen Keller, Chief Financial Officer · 2026-05-06 Operating cash flow is inflecting — $50M YTD vs. -$65M a year ago. A ~$20M Lugano recovery is expected this fall, with additional tax refunds possible.

The company remains committed to further asset sales. Zach Sawtelle, incoming CEO, stated: “We are still highly committed to an additional divestiture in order to accelerate the deleveraging process.” — Zachary Sawtelle, Chief Operating Officer · 2026-08-10 This is a continuation of the strategy laid out in prior quarters, but now with a concrete governance change and a higher sense of urgency. The same key themes — tariff refunds, debt reduction, and asset sale — dominated the call.

Altor: The Problem Child

Altor is the clear drag on the industrial segment. Adjusted EBITDA declined ~50% in Q2, with management citing tariff-related disruption in white goods, softer vaccine demand in cold chain, and higher input costs. But Zach was candid that internal execution is also to blame: “Our commercial execution has not been good enough, and we are urgently working to correct this issue.” — Zachary Sawtelle, Chief Operating Officer · 2026-08-10 The plan is to refocus commercial efforts on strength and cut costs, with a gradual recovery expected over the next 4–5 quarters. The market has rewarded the broader improvements — the stock is up 19% in the last 90 days — but it still trades at a deep discount, with price-to-revenue of just 0.3x versus a peak of 1.1x. If CODI can execute on the MSA fee reduction, a further asset sale, and a modest Altor recovery, the gap to intrinsic value could finally close.